Pentacel 29 Unit

Pentacel 29 Unit is a vaccine suspension used to protect against certain infectious diseases. This intramuscular injection contains inactivated poliovirus type 1 Mahoney and is manufactured by Sanofi Pasteur Limited in Canada.

Pentacel 29 Unit is primarily used for the prevention of poliomyelitis, a serious viral infection caused by the poliovirus. This vaccine is designed to help the body build immunity against the disease, reducing the risk of infection. It is typically administered as part of a vaccination schedule to ensure long-term protection.

Common effects of Pentacel 29 Unit may include mild redness, swelling, or tenderness at the injection site. Some individuals might experience mild fever, fatigue, or general discomfort following vaccination. These effects are usually temporary and resolve on their own.

Pentacel 29 Unit should be handled with care and stored according to the manufacturer's guidelines. It is important to inform healthcare providers about any allergies or medical conditions before receiving this vaccine. Always follow the advice of a healthcare professional regarding vaccination.

Pentacel 29 Unit may interact with other medications or vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving this vaccine. Avoid taking any other medications without consulting a healthcare professional.